Filing metadata

Accession number
0001209191-17-006266
Form type
Form 4
Filer
Revance Therapeutics, Inc.
CIK
CIK 1479290
Filed
Jan 30, 2017
Reporting period
Jan 26, 2017
Description
Insider transaction

Explore SEC Filings Hub